BridgeBio Pharma (BBIO) Share-based Compensation (2018 - 2026)
BridgeBio Pharma's Share-based Compensation was $44.07 million in Q2 2026, up 18.3% from $37.24 million a year earlier and up 32.6% from the prior quarter.
BridgeBio Pharma (BBIO) Share-based Compensation (2018 - 2026) Analysis & Trends
On a trailing twelve-month basis, BridgeBio Pharma's Share-based Compensation was $147.22 million through Jun 30, 2026, up 22.3% year-over-year; for FY2025, it came in at $133.02 million, up 38.9% from FY2024.
- Share-based Compensation shows a five-year compound annual growth rate of 17.9% (FY2020 to FY2025).
- In earlier years, Share-based Compensation was $95.8 million in FY2024 (-11.9%), $108.71 million in FY2023 (+18.7%), $91.56 million in FY2022 (-8.0%) and $99.51 million in FY2021 (+70.2%).
- The Q2 2026 figure marks the highest quarterly Share-based Compensation in data going back to Q3 2018.
- Compared with a year earlier, Share-based Compensation has increased for six straight quarters, with growth averaging 27.3% over the last eight quarters.
- The best year-over-year quarter for Share-based Compensation over five years was Q2 2025 (growth of 73.6%); the worst was Q1 2022 (a decline of 28.2%).
- Per Business Quant data, BBIO's Share-based Compensation in the three quarters before Q2 2026 was $33.24 million (Q1 2026), $34.64 million (Q4 2025) and $35.26 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.76 Bn | 1,105.35 Bn | 19.71 Bn | 201.00 Mn |
| 2 | Johnson & Johnson | 618.64 Bn | 537.17 Bn | 17.26 Bn | 458.00 Mn |
| 3 | AbbVie | 502.02 Bn | 475.13 Bn | 12.70 Bn | 166.00 Mn |
| 4 | Merck | 368.10 Bn | 322.48 Bn | 12.21 Bn | 298.00 Mn |
| 5 | Novartis Ag | 297.96 Bn | 261.95 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 261.11 Bn | 234.80 Bn | 12.86 Bn | - |
| 7 | Amgen | 236.64 Bn | 192.04 Bn | 7.24 Bn | 165.00 Mn |
| 8 | Gilead Sciences | 191.15 Bn | 165.35 Bn | 6.22 Bn | 231.00 Mn |
| 9 | Pfizer | 169.69 Bn | 116.33 Bn | 10.94 Bn | 249.00 Mn |
| 10 | BridgeBio Pharma | 13.33 Bn | 10.44 Bn | 228.63 Mn | 44.07 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 44.07 Mn |
| Mar 31, 2026 | 33.24 Mn |
| Dec 31, 2025 | 34.64 Mn |
| Sep 30, 2025 | 35.26 Mn |
| Jun 30, 2025 | 37.34 Mn |
| Mar 31, 2025 | 25.88 Mn |
| Dec 31, 2024 | 30.13 Mn |
| Sep 30, 2024 | 27.13 Mn |
| Jun 30, 2024 | 21.45 Mn |
| Mar 31, 2024 | 28.85 Mn |
| Dec 31, 2023 | 30.83 Mn |
| Sep 30, 2023 | 27.23 Mn |
| Jun 30, 2023 | 27.18 Mn |
| Mar 31, 2023 | 23.48 Mn |
| Dec 31, 2022 | 22.58 Mn |
| Sep 30, 2022 | 18.66 Mn |
| Jun 30, 2022 | 28.31 Mn |
| Mar 31, 2022 | 24.28 Mn |
| Dec 31, 2021 | 22.51 Mn |
| Sep 30, 2021 | 16.13 Mn |
BridgeBio Pharma Share-based Compensation API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=share-based-compensation&ticker=BBIO&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "share-based-compensation", "ticker": "BBIO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=share-based-compensation&ticker=BBIO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();